Log In
Print
BCIQ
Print
Print this Print this
 

BIO 300

  Manage Alerts
Collapse Summary General Information
Company Humanetics Corp.
DescriptionRadioprotectant inhibitor of protein tyrosine kinase (PTK) and topoisomerase II (TOP2)
Molecular Target Protein tyrosine kinase (PTK) ; Topoisomerase II (TOP2)
Mechanism of ActionRadioprotectant
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPoisoning
Indication DetailsPrevent and mitigate acute radiation syndrome (ARS); Treat and prevent acute radiation syndrome (ARS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today